Court Irons Out BOTOX® Wrinkle, Sales Price Reporting Required


Joshua Rogaczewski represented the maker of BOTOX® in a DC District Court proceeding focused on whether Medicare could apply its average sale price (ASP) reporting requirements on the product, even though it is not covered by Medicare. Read the full article.